Patents by Inventor Andrew Doherty

Andrew Doherty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1,3,4,7-tetrahydro-2H-pyrrolo[3?,2?:5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibitors
    Patent number: 11964990
    Abstract: The present invention provides for compounds of Formula (I) wherein A, L, W, and R1 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of CLL, SLL, and/or ALL.
    Type: Grant
    Filed: January 19, 2023
    Date of Patent: April 23, 2024
    Assignee: AbbVie Inc.
    Inventors: George A. Doherty, Vikram Bhat, Andrew S. Judd, Andrew J. Souers
  • Closed-loop perfusion circuit for cell and tissue cultures
    Patent number: 11898135
    Abstract: A closed-loop perfusion system may include a sealed biological culture container configured to house a biological cell culture, and a filtering unit that permits passage of waste products from an output of the sealed biological cell culture container, permits passage of nutrients from a nutrient media solution, and blocks passage of beneficial molecules from the output of the sealed biological cell culture container. The system may further include a first fluid path between an output of the sealed biological cell culture container and an input of the filtering unit, a second fluid path between an output of the filtering unit and an input of the sealed biological cell culture, and a pump to control the flow of media through the first fluid path and the second fluid path.
    Type: Grant
    Filed: June 30, 2020
    Date of Patent: February 13, 2024
    Assignee: CCLabs Pty Ltd
    Inventors: Hon Weng Chong, Chew Ling Lau, Andrew Doherty
  • DE-IDENTIFIED MEDICAL RECORDS AND RELATED SYSTEMS
    Publication number: 20220067864
    Abstract: An electronic healthcare data de-identification system can accept data containing personally-identifiable information and output de-identified healthcare data that is uniquely identifiable and has preserved temporal order. The unique identity of the de-identified healthcare data is preserved with universally unique identifiers and the temporal order of the de-identified healthcare data is maintained with universally unique sequence values that synchronize the timing of healthcare events. The embodiments described herein make healthcare data more accessible to users without endangering their privacy and allow conclusions to be made from large sets of data without restricting its use due to privacy concerns. Other embodiments are also described.
    Type: Application
    Filed: April 22, 2020
    Publication date: March 3, 2022
    Inventors: Alexander C. Walsh, Richard Castro, Paul G. Updike, Adam Andrew Doherty, Johan Prinsloo
  • Cloning and use of transaminase gene tyrB
    Patent number: 5091314
    Abstract: The isolation of the tyrB gene contained in E. coli ATCC 11303 and its cloning onto a multicopy plasmid results in a 10-fold increase in the L-phenylalanine yield after the transformation of the starting strain with this plasmid.
    Type: Grant
    Filed: August 13, 1990
    Date of Patent: February 25, 1992
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Rudiger Marquardt, Johann Then, Hans-Matthias Deger, Gerhard Wohner, Martyn K. Robinson, Andrew Doherty